Syra health delivers third quarter 2024 financial results

Achieved net revenue of $2.3 million, ~42% growth over the prior year quarter gross margins increased following shift in operational strategy net loss narrowed to $417,535 ($0.06 per share), a significant improvement from the $1.39 million ($0.21 per share) net loss in q2 of 2024 aiming to attain profitability in 2025 through targeted revenue growth and cost-efficiency measures conference call will be held today, tuesday, october 29 th at 9:00 am et carmel, ind. , oct. 29, 2024 /prnewswire/ -- syra health corp. (nasdaq: syra), ("syra health" or the "company") a healthcare technology company driving better health through impactful, innovative solutions, announced today its financial results for the third quarter ended september 30, 2024.
SYRA Ratings Summary
SYRA Quant Ranking